International Harm Reduction Consortium – We Will Not End AIDS Without Harm Reduction

Brief summary:

This project Implemented by International Harm reduction Consortium with include International Drug Policy Consortium (IDPC) as lead of Consortium, Harm Reduction International (HRI)

Youth RISE, Women and Harm Reduction International Network (WHRIN), Middle East and North Africa Harm Reduction Association (MENAHRA), Eurasian Harm Reduction Association (EHRA), Eurasian Network of People who Use Drugs (ENPUD) and

European Network of People who Use Drugs (EuroNPUD)

The Harm Reduction Consortium exists to challenge the global war on drugs (the critical factor affecting the rights of people who use drugs), to scale-up access to HIV-related harm reduction services, and to advocate for greater resources for harm reduction. The Consortium comprises leading international and regional harm reduction, drug policy and drug user networks, and it has a proven record of successful collaboration. Collectively, we seek to amplify civil society voices by linking-up international policy making processes with regional dialogues and mechanisms and, ultimately, the country-level work being done by our members and partners.

Aim / Objectives:

  • A global initiative to reframe the messaging, “storytelling” and communications around harm reduction and drug policies;
  • Coordinated advocacy around key UN structures such as the Commission on Narcotic Drugs (CND);
  • Coordinated advocacy and information sharing at key HIV-related fora and conferences;
  • The global Support Don’t Punish campaign enabling local partners and ISP groups to promote harm reduction and policy reforms;
  • Cross-consortium communications and network capacity building.
  • Each partner will also deliver their own high-impact HIV work, including research, resource development, CSO and ISP capacity building, and budget advocacy.

Within the Consortium activities, EHRA continues our work for advocacy of progressive drug policy and peer-to-peer and scientists mentoring support for and with community of people who use drugs:

  • Upgrade, modernise and communicate the harm reduction approach related to new psychoactive drug use in the region, taking into the consideration gender specific services.
  • Capacity building for civil society on advocacy for harm reduction, human rights and policy reform. Sub-grants and mentoring supporting for local advocacy projects in Eurasia.
  • Development of a ‘Criminalization Costs’ database in Eurasia. We continue developing the ‘Criminalization Costs’ database to present compelling financial arguments for harm reduction drug policy reform, by highlighting the costs of current punitive responses in various countries.
  • Strengthens EHRA team and members capacity to advocate for decriminalization and the initiation of alternative punitive approaches. Consortium-wide engagement, advocacy and support for civil society representation at the UN Commission on Narcotic Drugs (CND). The whole Consortium will engage again at this key policy fora, with 2019 being a particularly key year with a high-level Ministerial Segment in Vienna.

Countries covered by project:  Eastern and Northern Europe, the Baltic Countries and Central Asia

Project timeline: January 2019 – December 2021

Overall budget: The whole Consortium budget is 2 720 001 USD where EHRA budget is 406 191 USD for 3 years.

Project donor:  The Robert Carr civil society Networks Fund (RCF) 

The results of the Small grants competition